Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
[Serial] Front line of DDS development in pharmaceutical industries
Development strategy of KADCYLA (a HER2-targeted antibody and microtubule inhibitor conjugate) for the treatment of patients with inoperable or recurrent HER2-positive metastatic breast cancer
Kazumitsu Kanatani, Kumiko Miyata
Author information
JOURNAL FREE ACCESS

2014 Volume 29 Issue 5 Pages 460-467

Details
Download PDF (617K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Article 1st page
Content from these authors
© 2014 Japan Society of Drug Delivery System
Previous article Next article
Favorites & Alerts

Recently viewed articles
Share this page
feedback
 Top